Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation.

Remes, A M; Liimatta, E V; Winqvist, S; Tolonen, U; Ranua, J A; Reinikainen, K; Hassinen, I E; Majamaa, K

Remes, A M; Liimatta, E V; Winqvist, S; Tolonen, U; Ranua, J A; Reinikainen, K; Hassinen, I E; Majamaa, K.

Affiliation

Remes AM; Department of Neurology, University of Oulu, Oulu, Finland.

Neurology ; 59(8): 1275-7, 2002 Oct 22.

Article in En | MEDLINE | ID: mdl-12391367

Subject(s)

DNA, Mitochondrial/genetics; Mitochondrial Encephalomyopathies/drug therapy; Mutation/genetics; Niacinamide/therapeutic use; Ubiquinone/therapeutic use; Humans; Mitochondrial Encephalomyopathies/blood; Mitochondrial Encephalomyopathies/genetics; Statistics, Nonparametric; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Mitochondrial / Ubiquinone / Mitochondrial Encephalomyopathies / Niacinamide / Mutation Limits: Humans Language: En Journal: Neurology Year: 2002 Document type: Article

Search on Google

XML

PubMed Links